Search
for
Sort by
Research 841–870 of 1000+
- Hair loss
- Dermatologic manifestations of endocrine disorders
- Dermatosis associated with menopause
- Focal and Generalized Alopecia
- ‘Disappearing Foot Disease’: An Unusual Presentation of Primary Lymphoma of Bone
- Hair loss
- Symptom management in inflammatory bowel disease
- Association of Short-Term Exposure to Ambient Fine Particulate Matter with Skin Symptoms in Schoolchildren: A Panel Study in a Rural Area of Western Japan
- Diseases of Periocular Hair
- Microbial harmony in female reproductive health: exploring the impact of intestinal flora on ovarian function and disease pathogenesis
- Incipient Diabetes Mellitus and Nascent Thyroid Disease Presenting as Beard Alopecia Areata: Case Report and Treatment Review of Alopecia Areata of the Beard
- Evaluating Antiinflammatory and Antiandrogenic Effects of Garden Cress (Lepidium sativum L.) in HaCaT cells
- Endocrine disorders and hormonal therapy for adolescent acne
- Darier Sign: A Historical Note
- The role of multiomics in revealing the mechanism of skin repair and regeneration
- Potential Use of Spin Traps to Control ROS in Antipollution Cosmetics—A Review
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World
- Abstracts
- Rheumatologic Manifestations of Pregnancy
- New insights into inflammatory memory of epidermal stem cells
- Acne and acneiform eruptions
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review
- Differential diagnosis of posterior scalp hair loss
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Janus Kinase inhibitors in dermatology: a review
- Treatments for alopecia areata: a network meta-analysis
- Growth Differentiation Factor 11 (GDF11)/Transforming Growth Factor - β (TGF - β)/Mesenchymal Stem Cells (MSCs) Balance: A Complicated Partnership in Skin Rejuvenation
- 258 11β-hydroxysteroid dehydrogenase type 1 inhibition attenuates the adverse effects of glucocorticoids on dermal papilla cells